Autoimmune Disease Diagnostics Market Importance Analysis with Professional Study, Development Research Insights 2019 and Global Industry Forecast 2026
The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. Autoimmune diseases cause abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the major reason for development of autoimmune diseases. Some of the common autoimmune diseases among 80 types of autoimmune diseases are type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for autoimmune diseases is not yet available only relieving treatments are available for these diseases. Diagnosis of the autoimmune diseases can be done through tests which involve antinuclear antibody test, antibody test, complete blood counts, and some others.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/419
The growing incidence of autoimmune diseases and government initiatives to improve diagnosis and treatment of autoimmune diseases is expected to propel the market growth
According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50 million people suffered from autoimmune diseases in the U.S. with 75% being women. Increasing incidence of autoimmune diseases, rising public awareness and government initiatives taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of the factors which are driving the autoimmune disease diagnostics market. Many of the organizations and governments are funding the research and development program for autoimmune diseases which is expected to lead to increasing product launches and also aid growth of the autoimmune disease diagnostics market. For instance, discovery of novel biomarkers has proven to be significant for improving diagnosis of autoimmune diseases.
However, factors such as high rate of false results, slow turnaround time for test results and lack of experience and education of laboratory personnel in the diagnosis of certain autoimmune diseases is expected to restrain the market growth over the forecast period.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/419
Aging population and technological advancements in diagnosis of rheumatoid arthritis are projected to favor growth of the rheumatoid arthritis segment
The high patient awareness level and large procedure volumes are the reasons why localized autoimmune disease diagnostics are dominating the overall market. However, initiatives taken by governments for patients suffering from rheumatoid arthritis and systemic lupus erythematosus are expected to aid growth of the systemic autoimmune disease diagnostics segment.
On the basis of region, the autoimmune disease diagnostics market is segmented into North America, Europe, Asia Pacific, Middle East, and Africa. North America is one of the largest revenue contributors in the global autoimmune disease diagnostics industry due to rising incidence of autoimmune diseases such as rheumatoid arthritis and type1 diabetes. The increase in funding by government and private sector, increasing regulatory scenario monitored by World Health Organization (WHO), and technological advancements are some of the factors which are driving growth of the autoimmune disease diagnostics market in the North America region. Asia Pacific is projected to be the fastest growing regional market in the global autoimmune disease diagnostic market.
Global Autoimmune Disease Diagnostic Market-Competitive Landscape
The key players operating the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and others.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/autoimmune-disease-diagnostics-market-419
In July 2019, Progentec Diagnostics, Inc. merged with Karate Health, Inc. to offer laboratory testing and digital technologies for diagnosis and management of autoimmune diseases.
In March 2019, Eli Lilly collaborated with ImmuNext to study and develop a preclinical novel potential target for autoimmune disease treatment.
In January 2019, Vital Therapies, Inc. and Immunic AG entered into a definitive agreement in which Vital Therapies, Inc. focused on Immunic‘s pipeline of novel and potentially transformative treatments for chronic inflammatory and autoimmune diseases.
In 2018, Quidel Corporation received CE mark for its Sofia Quantitative Vitamin D FIA for use with Sofia fluorescent immunoassay analyzer.
In 2017, ImmunArray and Kindstar Global Co., Ltd. announced a partnership and introduced ImmunArray’s lupus rule-out test in China.
Global Autoimmune Disease Diagnostic Market-Taxonomy
The global autoimmune disease diagnostic market are segmented on the basis of disease type, test type, end-user, and region.
By Disease Type:
- Systemic Autoimmune Disease diagnostics
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus
- Localized autoimmune disease diagnostics
- Multiple Sclerosis
- Type 1 diabetes
- Hashimoto’s thyroiditis
- Idiopathic Thrombocytopenic purpura
By Test Type:
- Antinuclear Antibody Tests
- Autoantibody Tests
- Complete Blood Count
- C-reactive Protein
By End User:
- Diagnostics Centers
- Research Laboratories
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire